Tag: investment
-

Q3 Venture Funds Inch Up, Early-Stage Deals Drop
Venture capital funding rose in the third quarter of 2020, driven in large part by investments in already established companies rather than newer enterprises.
-

Lilly Gains Neuro Disease Biotech in $1.36B Deal
Drug maker Eli Lilly and Co. is acquiring Disarm Therapeutics, a biotechnology company developing treatments for neurodegenerative disorders.
-

New Company IDs Drugs Targeting Cancer Cell Networks
A start-up company is using artificial intelligence to discover drugs that address the tumor stroma, a cellular network supporting cancerous tumors.
-

Microbiome Therapies Company Unveils, Raises $50M
A new enterprise is underway developing therapeutics targeting bacterial communities in the body, to treat metabolic disorders and cancer.
-

Heart Disease Biotech Acquired in $13.1B Deal
A company developing precision medicine drugs to treat inherited heart disorders was acquired by drug maker Bristol Myers Squibb, or BMS, for $13.1 billion.
-

Infographic – Global Climate Technology Hubs
The report also highlights where the investments were made, with the geographic hubs or clusters attracting the most investments, this weekend’s infographic.
-

Chip-Based RNA Biotech Raises $60M in Venture Funds
A company developing messenger RNA therapeutics on demand from single-use biochips is raising $60 million in its second venture funding round.
-

Cancer Screening Analytics Company Acquired in $8B Deal
A company creating a blood test to screen for multiple types of cancer is being acquired by genomics analytics company Illumina for $8 billion in cash and stock.
-

Mental Health Drug Company Raises $127.5M in IPO
A company developing a drug for depression based on synthesized compounds in hallucinogenic substances is raising $127.5 million in its initial public stock offer.
-

Precision Cancer Therapy Start-Up Gains $110M in Early Funds
A company creating cancer therapies with individualized engineered T-cells is raising $110 million in its first venture funding round.